Clinical Trial Update: Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy [NA]

View source ↗

Summary

Clinical trial evaluating how biological age and frailty influence management of chronic myeloid leukemia treated with targeted therapy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Leukemia,Myeloid, Chronic | NA | Status: RECRUITING